Bioharvest SEC Filings

BHST NASDAQ

Welcome to our dedicated page for Bioharvest SEC filings (Ticker: BHST), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

BioHarvest Sciences Inc. (BHST) disrupts biotechnology with its patented Botanical Synthesis platform—think yeast fermentation, but for whole-plant molecules. Investors scanning BioHarvest Sciences SEC filings want clarity on how nutraceutical sales and CDMO contracts convert breakthrough science into revenue, yet Form 10-K and 10-Q sections on R&D, scalability, and regulatory pathways can feel impenetrable.

Stock Titan delivers BioHarvest Sciences SEC filings explained simply. Our AI reads every line, then surfaces what matters: segment revenue shifts, patent portfolio updates, and consumption trends in cardiovascular health products found inside the BioHarvest Sciences annual report 10-K simplified. Need to track management moves? Receive BioHarvest Sciences Form 4 insider transactions real-time—no more manual EDGAR searches for BioHarvest Sciences insider trading Form 4 transactions.

Whether you’re researching a BioHarvest Sciences quarterly earnings report 10-Q filing, verifying BioHarvest Sciences proxy statement executive compensation, or parsing a sudden BioHarvest Sciences 8-K material events explained, the platform keeps you informed. Key features include:

AI-powered summaries that translate dense disclosures into plain language, perfect for understanding BioHarvest Sciences SEC documents with AI.
Real-time alerts the moment a BioHarvest Sciences executive stock transactions Form 4 posts.
Unified access to every filing type—from R&D milestone 8-Ks to earnings report filing analysis—updated within seconds of EDGAR release.

Analysts use these insights to:

Compare quarter-over-quarter nutraceutical margins
Monitor insider buying ahead of new CDMO contracts
Validate capital needs against large-scale bioreactor expansion

Skip the 200-page PDFs. Stock Titan’s AI-powered analysis distills BioHarvest Sciences disclosures into clear, decision-ready insights before the market opens.

07/03/2025 10:42 AM

Filing

[6-K] BioHarvest Sciences Inc. Current Report (Foreign Issuer)

Rhea-AI Summary

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

FAQ

What is the current stock price of Bioharvest (BHST)?

The current stock price of Bioharvest (BHST) is $6.9 as of July 3, 2025.

What is the market cap of Bioharvest (BHST)?

The market cap of Bioharvest (BHST) is approximately 117.8M.

What is the core technology behind BioHarvest Sciences Inc?

BioHarvest utilizes a patented Botanical Synthesis technology to grow plant cell cultures that produce active, bioengineered plant molecules without traditional farming methods, ensuring consistency and scalability.

How does BioHarvest generate revenue?

The company operates through two primary channels: creating its own proprietary nutraceutical health products and offering CDMO services to develop complex, plant-derived pharmaceutical and cosmetic ingredients for partnering businesses.

What makes BioHarvest’s approach unique in the biotechnology industry?

By bypassing conventional agriculture and using controlled plant cell growth methods, BioHarvest produces high-quality, patentable bioactive compounds in a sustainable and resource-efficient manner, setting it apart from traditional extraction techniques.

Who are the typical customers for BioHarvest?

BioHarvest serves both end-consumers through its nutraceutical product lines and industrial partners, including pharmaceutical, cosmetic, and nutrition companies, via its CDMO services.

What role do strategic partnerships play for BioHarvest?

Strategic collaborations, such as those with established global ingredient companies, help expand the applications of their Botanical Synthesis technology, enhancing product innovation and market reach across various sectors.

How does BioHarvest address quality and scalability in its production?

The company invests in advanced R&D, digitized manufacturing processes, and sustainable production infrastructure to ensure consistent quality, optimize efficiency, and scale its operations to meet both consumer and industrial demands.

What industries does BioHarvest serve with its technology?

BioHarvest’s technology is applicable in various sectors including nutraceuticals, pharmaceuticals, cosmetics, and food ingredients, allowing it to address diverse market needs with its plant-based compounds.

Bioharvest

NASDAQ:BHST

BHST Rankings

#6531 Ranked by Market Cap

N/A Ranked by Dividends

BHST Stock Data

Market Cap 117.83M

Float 12.82M

Insiders Ownership 25.98%

Institutions Ownership 0.51%

Short Percent 0.02%

Industry Packaged Foods

Sector Consumer Defensive

Website Link

Country Canada

City Vancouver